Maesaka John K, Imbriano Louis J, Miyawaki Nobuyuki
John K Maesaka, Louis J Imbriano, Nobuyuki Miyawaki, Department of Medicine and Division of Nephrology and Hypertension, Winthrop-University Hospital, Mineola, NY 11501, United States.
World J Nephrol. 2017 Mar 6;6(2):59-71. doi: 10.5527/wjn.v6.i2.59.
Hyponatremia, serum sodium < 135 mEq/L, is the most common electrolyte abnormality and is in a state of flux. Hyponatremic patients are symptomatic and should be treated but our inability to consistently determine the causes of hyponatremia has hampered the delivery of appropriate therapy. This is especially applicable to differentiating syndrome of inappropriate antidiuresis (SIAD) from cerebral salt wasting (CSW) or more appropriately, renal salt wasting (RSW), because of divergent therapeutic goals, to water-restrict in SIAD and administer salt and water in RSW. Differentiating SIAD from RSW is extremely difficult because of identical clinical parameters that define both syndromes and the mindset that CSW occurs rarely. It is thus insufficient to make the diagnosis of SIAD simply because it meets the defined characteristics. We review the pathophysiology of SIAD and RSW, the evolution of an algorithm that is based on determinations of fractional excretion of urate and distinctive responses to saline infusions to differentiate SIAD from RSW. This algorithm also simplifies the diagnosis of hyponatremic patients due to Addison's disease, reset osmostat and prerenal states. It is a common perception that we cannot accurately assess the volume status of a patient by clinical criteria. Our algorithm eliminates the need to determine the volume status with the realization that too many factors affect plasma renin, aldosterone, atrial/brain natriuretic peptide or urine sodium concentration to be useful. Reports and increasing recognition of RSW occurring in patients without evidence of cerebral disease should thus elicit the need to consider RSW in a broader group of patients and to question any diagnosis of SIAD. Based on the accumulation of supporting data, we make the clinically important proposal to change CSW to RSW, to eliminate reset osmostat as type C SIAD and stress the need for a new definition of SIAD.
低钠血症,即血清钠<135mEq/L,是最常见的电解质异常,且情况多变。低钠血症患者有症状,应接受治疗,但我们一直无法确定低钠血症的病因,这阻碍了恰当治疗的实施。这在区分抗利尿激素分泌异常综合征(SIAD)与脑性盐耗综合征(CSW),或更确切地说,与肾性盐耗综合征(RSW)时尤为适用,因为两者的治疗目标不同,SIAD需限水,而RSW则需补充盐和水。区分SIAD与RSW极其困难,因为定义这两种综合征的临床参数相同,而且人们认为CSW很少发生。因此,仅仅因为符合既定特征就诊断为SIAD是不够的。我们回顾了SIAD和RSW的病理生理学,以及一种算法的演变,该算法基于尿酸排泄分数的测定和对盐水输注的独特反应来区分SIAD与RSW。该算法还简化了因艾迪生病、渗透压调定点重置和肾前状态导致的低钠血症患者的诊断。人们普遍认为,我们无法通过临床标准准确评估患者的容量状态。我们的算法无需确定容量状态,因为认识到有太多因素会影响血浆肾素、醛固酮、心房/脑钠肽或尿钠浓度,使其无法发挥作用。因此,关于无脑部疾病证据的患者中出现RSW的报道以及对此认识的不断增加,应该促使我们在更广泛的患者群体中考虑RSW,并对任何SIAD诊断提出质疑。基于支持数据的积累,我们提出一项具有临床重要性的建议,将CSW改为RSW,将渗透压调定点重置从C型SIAD中剔除,并强调需要对SIAD进行新的定义。